About Cardiovascular Ultrasound System
Cardiovascular ultrasound systems are the systems that use sound waves to create images of the heart. This ultrasound system helps to investigate patient's clinical symptoms and assess heart conditions such as murmurs or damage to the heart due to prior heart attack or infection. The factors such as Increase Workflow Efficiency and Automate Workflows, Increased Prevalence of Cardiovascular Diseases and Development of New Diagnostic Centres and Hospitals are the key drivers for the global Cardiovascular Ultrasound System market. In addition, the trend of Adding AI to Ultrasound Systems also fueling the market growth.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cardiovascular Ultrasound System market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
GE Healthcare (United States), Esaote S.P.A. (Italy), Henry Schein Medical (United States), Siemens Healthineers AG (Germany), Samsung Electronics Co., Ltd. (South Korea), Philips Healthcare (Netherlands), Toshiba Medical Systems (Japan), Unetixs Vascular, Inc. (United States), Hitachi Medical Corporation (Japan), Ultrasound Technologies Ltd (United Kingdom) and Fujifilm Holdings Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Chison Medical Imaging Co., Ltd. (China), Shenzhen Bestman Instrument Co., Ltd. (China) and Mindray Medical International Limited (China).
Segmentation Overview
AMA Research has segmented the market of Global Cardiovascular Ultrasound System market by Type (2D Ultrasound, 3D & 4D Ultrasound and Doppler Imaging), Application (Hospitals, Cardiology Centers, Home Care, Ambulatory Care Settings and Others) and Region.
On the basis of geography, the market of Cardiovascular Ultrasound System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online Channel will boost the Cardiovascular Ultrasound System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Adding AI to Ultrasound Systems Increases Diagnostic Capabilities
Market Growth Drivers:
Increase Workflow Efficiency and Automate Workflows, Increased Prevalence of Cardiovascular Diseases and Development of New Diagnostic Centres and Hospitals
Challenges:
Dearth of Skilled and Experienced Sonographers
Restraints:
High Cost of Cardiovascular Ultrasound Systems
Opportunities:
Growth in the Healthcare Industry Worldwide and Robust Increase in the Distribution Channels
Market Leaders and their expansionary development strategies
In October 2020, GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.
In August 2023, Siemens Healthineers launches the Acuson Origin1, a dedicated cardiovascular ultrasound system with new, robust artificial intelligence (AI) features. Designed to improve patient outcomes and help physicians perform minimally invasive cardiac procedures more efficiently, the Acuson Origin addresses the entire continuum of cardiovascular patient care, including diagnostic, structural heart, electrophysiological, and pediatric procedures.
Key Target Audience
Cardiovascular Ultrasound System Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.